Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Acta Paediatrica (Oslo, Norway : 1992)|May 3, 2003
Implementation of a nation-wide automated auditory brainstem response hearing screening programme in neonatal intensive care unitsH L M van Straaten, E T M Hille, J H Kok, et al.
Pediatrics|November 3, 2005
Nonresponse bias in a follow-up study of 19-year-old adolescents born as preterm infantsE T M Hille, L Elbertse, J Bennebroek Gravenhorst, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 29, 2011
Professionals' opinion on follow-up in breast cancer patients; perceived purpose and influence of patients' risk factorsM van Hezewijk, E T M Hille, A N Scholten, et al.
Diabetologia|February 2, 2006
Preterm birth and later insulin resistance: effects of birth weight and postnatal growth in a population based longitudinal study from birth into adult lifeM J J Finken, M G Keijzer-Veen, F W Dekker, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 19, 2010
Tailored follow-up for early breast cancer patients: a prognostic index that predicts locoregional recurrenceJ G H van Nes, H Putter, M van Hezewijk, et al.
Early Human Development|September 10, 2005
Is attrition bias a problem in neonatal follow-up?E T M Hille, A L den Ouden, M C Stuifbergen, et al.
Archives of Disease in Childhood. Fetal and Neonatal Edition|September 23, 2008
Intelligence of very preterm or very low birthweight infants in young adulthoodN Weisglas-Kuperus, E T M Hille, H J Duivenvoorden, et al.
Journal of Thrombosis and Haemostasis : JTH|August 31, 2004
Preeclampsia and its interaction with common variants in thrombophilia genesM P M De Maat, M W J C Jansen, E T M Hille, et al.
Breast Cancer Research and Treatment|March 29, 2012
Quality of life in relation to tamoxifen or exemestane treatment in postmenopausal breast cancer patients: a Tamoxifen Exemestane Adjuvant Multinational (TEAM) Trial side studyJ G H van Nes, D B Y Fontein, E T M Hille, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 7, 2012
Relationship between specific adverse events and efficacy of exemestane therapy in early postmenopausal breast cancer patientsD B Y Fontein, D Houtsma, E T M Hille, et al.
Pageof 2